Literature DB >> 1711233

Reverse-transcriptase-associated RNaseH activity mediates template switching during reverse transcription in vitro.

J Garcés1, R Wittek.   

Abstract

During the first steps of reverse transcription of the retroviral genome, sequences present at the extremities of the RNA are used to reconstitute a host cell PolII promoter. The assembly of the promoter occurs by template switching, which takes advantage of a direct repeat at the ends of the RNA molecule. These steps are catalysed by the viral reverse transcriptase, which carries an intrinsic RNaseH activity that is probably also involved therein. To study the role of the RNaseH activity in this first template-switching event, an in vitro system has been developed based on primer extensions of synthetic RNAs. When an RNA was reverse transcribed with wild-type reverse transcriptase in the presence of a second RNA the 3' part of which was repeated at the 5' end of the first one, extension products could be observed corresponding to a chimeric cDNA comprising both RNA species. This template switching could not be detected when a mutant reverse transcriptase lacking the RNaseH activity was used. The results show that the RNaseH activity is needed to remove the 5' RNA sequences from the cDNA:RNA hybrid thereby enabling its translocation to another RNA containing an appropriate complementary target sequence.

Mesh:

Substances:

Year:  1991        PMID: 1711233     DOI: 10.1098/rspb.1991.0037

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  10 in total

1.  Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.

Authors:  E S Svarovskaia; K A Delviks; C K Hwang; V K Pathak
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.

Authors:  E K Halvas; E S Svarovskaia; V K Pathak
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Effects on DNA synthesis and translocation caused by mutations in the RNase H domain of Moloney murine leukemia virus reverse transcriptase.

Authors:  S W Blain; S P Goff
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis.

Authors:  R R Bowman; W S Hu; V K Pathak
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Reactivation of transcription from a vaccinia virus early promoter late in infection.

Authors:  J Garcés; K Masternak; B Kunz; R Wittek
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Sequences in the 5' and 3' R elements of human immunodeficiency virus type 1 critical for efficient reverse transcription.

Authors:  Y Ohi; J L Clever
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 7.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

8.  A succession of mechanisms stimulate efficient reconstituted HIV-1 minus strand strong stop DNA transfer.

Authors:  Min Song; Mini Balakrishnan; Robert J Gorelick; Robert A Bambara
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

9.  Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.

Authors:  Zahida Parveen; Muhammad Mukhtar; Adrienne Goodrich; Edward Acheampong; Ralph Dornburg; Roger J Pomerantz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Cross-packaging of genetically distinct mouse and primate retroviral RNAs.

Authors:  Noura Salem Al Dhaheri; Pretty Susan Phillip; Akela Ghazawi; Jahabar Ali; Elizabeth Beebi; Soumeya Ali Jaballah; Tahir A Rizvi
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.